세계의 혈소판유래성장인자(PDGFs) 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Platelet-derived Growth Factors (PDGFs) Market is presumed to reach the market size of nearly USD 493.9 Million by 2032 from USD 257.4 Million in 2023 with a CAGR of 7.51% under the study period 2024-2032.

Platelet-derived growth factors (PDGFs) are proteins present in platelets. They are pivotal for wound healing and tissue regeneration and influence essential cellular functions such as proliferation, migration, and angiogenesis. When an injury occurs, platelets release PDGFs to attract cells necessary for tissue repair, such as fibroblasts and smooth muscle cells. PDGFs are used therapeutically in treatments to enhance healing in chronic wounds, surgical sites, and orthopedic injuries. By promoting the body's natural healing processes, PDGFs help accelerate recovery and improve the outcomes of regenerative therapies.

MARKET DYNAMICS

The platelet-derived growth factors (PDGFs) market is driven by their critical role in wound healing and tissue regeneration. The surging incidence of chronic wounds, such as pressure sores and diabetic foot ulcers, has significantly boosted the demand for PDGFs. Advancements in biotechnology have enabled the development of more effective and targeted PDGF formulations, enhancing their therapeutic potential. The growing uptake of regenerative medicine and tissue engineering techniques further propels the platelet-derived growth factors (PDGFs) market. Additionally, the escalating awareness among healthcare professionals about the benefits of PDGFs in accelerating the healing process is driving their usage in clinical settings. The expanding elderly population, more susceptible to chronic wounds and surgeries, also contributes to market growth. Moreover, substantial investments in research and development activities aimed at exploring new applications of PDGFs are expected to create new growth opportunities. However, the complex regulatory environment and high production costs may challenge the platelet-derived growth factors (PDGFs)market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet-derived Growth Factors (PDGFs). The growth and trends of Platelet-derived Growth Factors (PDGFs) industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet-derived Growth Factors (PDGFs) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• PDGF-AA
• PDGF-BB
• PDGF-CC
• PDGF-DD
• PDGF-AB

By Application

• Orthopedic Surgeries
• Cardiac Surgeries
• Cancer Treatment
• Wound Healing
• Others

By End-User

• Hospitals
• Clinics
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet-derived Growth Factors (PDGFs) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet-derived Growth Factors (PDGFs) market include Thermo Fisher Scientific Inc. (PeproTech Inc.), Stryker, Sigma-Aldrich (Merck KGaA), OriGene Technologies, IXCells Biotechnologies, Abbexa Ltd, Bio-Techne, Stemcell Technologies, Neuromics, GenScript Biotech Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PLATELET-DERIVED GROWTH FACTORS (PDGFS) - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. PDGF-AA Historic and Forecast Sales By Regions
• 5.4. PDGF-BB Historic and Forecast Sales By Regions
• 5.5. PDGF-CC Historic and Forecast Sales By Regions
• 5.6. PDGF-DD Historic and Forecast Sales By Regions
• 5.7. PDGF-AB Historic and Forecast Sales By Regions

6. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Orthopedic Surgeries Historic and Forecast Sales By Regions
• 6.4. Cardiac Surgeries Historic and Forecast Sales By Regions
• 6.5. Cancer Treatment Historic and Forecast Sales By Regions
• 6.6. Wound Healing Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-User
• 7.2. Historical and Forecast Data Analysis By End-User
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Clinics Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET-DERIVED GROWTH FACTORS (PDGFS) COMPANIES

• 9.1. Platelet-derived Growth Factors (PDGFs) Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF PLATELET-DERIVED GROWTH FACTORS (PDGFS) INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc. (PeproTech Inc.)
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Stryker
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Sigma-Aldrich (Merck KGaA)
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. OriGene Technologies
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. IXCells Biotechnologies
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Abbexa Ltd
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Bio-Techne
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Stemcell Technologies
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Neuromics
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. GenScript Biotech Corporation
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies